Recently, Dr. Sun Yimin, President of CapitalBiotech, along with Dr. Li Yanze, Assistant President, visited Kyrgyzstan to hold a working meeting with officials from the Chinese Embassy in Kyrgyzstan. During the same period, at the 19th MedExpo Kyrgyzstan, Kanatbek Temirbekovich Bekboyev, Minister of Health of Kyrgyzstan, visited the CapitalBiotech’ booth and held in-depth discussions with Dr. Sun and his delegation, further advancing the construction of the Kyrgyzstan National Precision Medicine Center.
As the joint construction of the Belt and Road Initiative enters a new stage of high-quality development, CapitalBiotech is committed to seizing this opportunity and working closely with Kyrgyz partners to steadfastly promote high-quality cooperation under the BRI framework.
What is In Vitro Diagnostic Reagents?April 4, 2023In vitro diagnostic reagents refer to in vitro diagnostic reagents managed by medical device management, including reagents, reagent kits, calibration products, quality control products, etc. used for...view
Development of Transcriptome Sequencing TechnologyApril 4, 2023Transcriptome refers to the total sum of all expressed genes in a specific cell under specific functional conditions, which includes all transcript information of a cell. Typically, transcriptome anal...view
Basic Performance of In Vitro Diagnostic Reagent ProductsMarch 9, 20231. Blank IVD in vitro diagnostic reagentsThe reagent blank can be understood as the value detected when the content of the substance to be tested is the theoretical zero value. The general practice is...view